Skip to main content
Equibles

Weaver Consulting Group

Position in BCLI — Brainstorm Cell Therapeutics Inc.

CIK 1780055 HUNTINGTON BEACH, CA
Back to BCLI Full portfolio

Position in BCLI

as of Jun 30, 2025 · filed Aug 12, 2025
Position Value
$17,497
-$2,187 QoQ
Shares Held
15,623
0.0% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BCLI Over Time

Shares Held

Position Value (USD)

Derivatives in BCLI

reported options exposure · as of Dec 31, 2023
CallValue
$500
CallShares
667
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Weaver Consulting Group holds $31,723 across 1 Biotechnology name.

# Ticker Company Shares Value (USD) Open
1 FBIO
Fortress Biotech, Inc.
 10,367 $31,723

All Filings in BCLI

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2025-06-30 $17,497 15,623
2025-03-31 $19,684 15,623
2024-12-31 $35,464 15,623
2024-09-30 $53,901 234,356
2024-06-30 $79,681 234,356
2024-03-31 $111,639 199,356
2023-12-31 $53,826 199,356
2023-12-31 $500 10,000
2023-09-30 $19,871 99,356
2023-09-30 $9,000 45,000
2023-06-30 $42,539 50,900
2023-06-30 $133,308 64,713
2023-03-31 $210,252 63,713
2023-03-31 $98,670 29,900
2022-12-31 $33,521 53,500
2022-12-31 $108,153 65,947
2022-09-30 $20,000 70,000
2022-09-30 $415,356 93,972
2022-06-30 $288,842 104,653
2022-03-31 $436,800 130,000
2021-12-31 $622,000 155,500
2021-09-30 $169,950 51,500
2021-06-30 $185,747 48,881
2021-03-31 $191,500 50,000